← ANALYST RATINGS · TIPRANKS
Certara (CERT): analyst forecast and price target
Analyst consensus
Hold1 Buy6 Hold0 Sell
Ratings of 7 analysts in the last 3 months · top analysts only12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $9.20, the highest $11.00, the lowest $7.00. The average is −1.8% from the last price of $9.37.
Analyst ratings 16
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | $9.00 → $12.00+33.3% | Buy | +28.1% | Reiterated | 16.10.26on TipRanks 07:40 | −1.9% | ↗ |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $9.00 → $11.00+22.2% | Buy | +17.4% | Reiterated | 13.10.26on TipRanks 09:00 | +3.9%next day −1.4% | ↗ |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 13.10.26on TipRanks 06:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $9.00 → $9.50+5.6% | Hold | +1.4% | Reiterated | 13.10.26on TipRanks 06:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 13.10.26on TipRanks 06:05 | — | |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $9.00 → $9.50+5.6% | Hold | +1.4% | Reiterated | 11.10.26on TipRanks 05:06 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.00 → $9.50+5.6% | Hold | +1.4% | Reiterated | 11.10.26on TipRanks 05:06 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 11.10.26on TipRanks 05:06 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $8.50 → $9.00+5.9% | Hold | −3.9% | Reiterated | 11.10.26on TipRanks 05:06 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $9.00 → $9.50+5.6% | Hold | +1.4% | Reiterated | 11.10.26on TipRanks 05:06 | — | |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $10.00 → $9.00−10.0% | Hold | −3.9% | Reiterated | 09.10.26on TipRanks 05:06 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $10.00 → $9.00−10.0% | Hold | −3.9% | Reiterated | 09.10.26on TipRanks 05:06 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $10.00 → $9.50−5.0% | Hold | +1.4% | Reiterated | 09.10.26on TipRanks 05:06 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $9.50 → $8.50−10.5% | Hold | −9.3% | Reiterated | 09.10.26on TipRanks 05:06 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $10.00 → $9.00−10.0% | Hold | −3.9% | Reiterated | 09.10.26on TipRanks 05:06 | — | |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $7.50 → $9.00+20.0% | Hold | −3.9% | Reiterated | 07.10.26on TipRanks 03:55 | −3.1%next day −3.1% · 5 days +5.4% | ↗ |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $9.00 → $9.50+5.6% | Hold | +1.4% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $9.50 → $10.00+5.3% | Hold | +6.7% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $8.00 → $10.00+25.0% | Hold | +6.7% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $10.00 | Hold | +6.7% | Initiated | 30.09.26on TipRanks 05:40 | −0.4%next day +1.3% · 5 days −4.5% | ↗ |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $9.50 | Hold | +1.4% | Reiterated | 29.09.26on TipRanks 05:07 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.50 | Hold | +1.4% | Reiterated | 29.09.26on TipRanks 05:07 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $10.00 | Hold | +6.7% | Reiterated | 29.09.26on TipRanks 05:07 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $9.00 | Hold | −3.9% | Reiterated | 29.09.26on TipRanks 05:07 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $9.50 | Hold | +1.4% | Reiterated | 29.09.26on TipRanks 05:07 | — | |
| Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% | Morgan Stanley | $9.00 | Hold | −3.9% | Reiterated | 17.09.26on TipRanks 07:08 | +4.4%next day −2.0% · 5 days +2.8% | ↗ |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $8.50 → $8.00−5.9% | Hold | −14.6% | Reiterated | 11.09.26on TipRanks 06:05 | — | |
| Joseph Vruwink★★★★★★★★★★#1159 · hits 59% · avg +7.8% | Robert W. Baird | $6.00 → $7.00+16.7% | Hold | −25.3% | Reiterated | 05.08.26on TipRanks 08:10 | +2.9%next day +1.7% · 5 days −0.4% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $6.50 → $7.50+15.4% | Hold | −20.0% | Reiterated | 05.08.26on TipRanks 04:13 | +2.9%next day +1.7% · 5 days −0.4% | ↗ |
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Hold | — | Reiterated | 05.08.26on TipRanks Aug 4 08:51 | −6.4%next day +2.9% · 5 days +4.3% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $6.00 → $8.00+33.3% | Hold | −14.6% | Reiterated | 04.08.26on TipRanks Aug 5 07:30 | −6.4%next day +2.9% · 5 days +4.3% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $9.00 | Buy | −3.9% | Reiterated | 04.08.26on TipRanks Aug 5 02:50 | −6.4%next day +2.9% · 5 days +4.3% | ↗ |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | — | Hold | — | Reiterated | 04.08.26on TipRanks 09:43 | −6.4%next day +2.9% · 5 days +4.3% | ↗ |
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | $8.00 | Buy | −14.6% | Reiterated | 16.06.26on TipRanks 10:35 | +16.7%next day +0.9% · 5 days −8.2% | ↗ |
| Jeffrey Garro★★★★★★★★★★#12266 · hits 30% · avg −24.4% | Stephens | $10.00 → $9.00−10.0% | Buy | −3.9% | Reiterated | 12.05.26on TipRanks 07:40 | −0.6%next day −6.5% · 5 days −9.2% | ↗ |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | $10.00 → $8.00−20.0% | Buy | −14.6% | Assigned | 13.04.26on TipRanks 05:10 | +3.3%next day −0.7% · 5 days +3.6% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $15.00 → $10.00−33.3% | Buy | +6.7% | Assigned | 09.03.26on TipRanks Mar 7 08:45 | −1.2%next day −1.4% · 5 days −6.4% | ↗ |
| Jamie Clark★★★★★★★★★★#6680 · hits 75% · avg +5.9% | Rothschild & Co Redburn | $10.00 | Buy | +6.7% | Initiated | 21.11.25on TipRanks 05:40 | +6.6%next day +1.1% · 5 days −0.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Certara
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $8.42 at a price of $9.20 (−8.5%); now: $9.43 at $9.37 (+0.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 1 | 2 |
| Hold | 11 | 13 | 9 | 9 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.09 (from $0.06 to $0.10). Last quarter: $0.08.
Sales
Next quarter’s sales estimate — $92M (from $90M to $97M). Last quarter: $93M.
Best top-analyst consensus in the sector · Healthcare
About Certara
- CEO: Jon Resnick
- Employees: 1,546
- 4 Radnor Corporate Center, Radnor, PA, 19087, US
- www.certara.com
Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.
Data from the stock’s TipRanks forecast page, read 21 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗